SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-24-003946
Filing Date
2024-07-08
Accepted
2024-07-08 17:23:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 d11408321_13-g.htm SC 13G 139088
  Complete submission text file 0000919574-24-003946.txt   140903
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Subject) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90788 | Film No.: 241105828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 119 ROWAYTON AVENUE 2ND FLOOR NORWALK CT 06853
Business Address 119 ROWAYTON AVENUE 2ND FLOOR NORWALK CT 06853 212-230-3220
DIALECTIC CAPITAL MANAGEMENT, LP (Filed by) CIK: 0001411512 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G